| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > Don't Mail Postcards to Generate Appointments in Financial Services Direct Mail Lead Generation |
|
Digg It - Don't Mail Postcards to Generate Appointments in Financial Services Direct Mail Lead Generation
I know a company that helps financial services
professionals generate sales leads by hosting free
financial planning seminars, usually with lunch o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product r
dinner included. The company mails full-color postcards to consumers, promoting the seminar at a nearby hotel. “There is no cost or obligation ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in for this
informative workshop, and the delicious meal is free
to all who attend,” promises the postcard copy. Naturally, those who attend hear a s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. les pitch of one
kind or another, and have a chance to meet some
local financial planners face to face. The financial
planners offer these free s here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe minars as a way to get in
front of a room full of potential clients at a
reasonable cost. The mistake this company is about to make is thinking d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t can set up face-to-face, private
appointments with prospective clients using
postcards as well. The postcards work well at filling
seminars, so ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the company thinks postcards will work
equally well at generating appointments. This company is mistaken. For a number of reasons. 1. The number- easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ne deal breaker for a consumer when
looking for a financial planner is trust. Consumers
want their financial planner to be educated, and
have the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically necessary credentials and experience, but
if they can’t trust the financial planner they won’t
hire him. And they won’t meet with him for a sales
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ appointment if they don’t know if they can trust him.
The problem with postcards is you can’t use them to
build trust. They look like they are mail ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d to
everyone in the neighbourhood. You can’t build trust
with “Dear Homeowner.” 2. Postcards by their very nature look like they are selling a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a roduct rather than a long-term relationship
with a financial planner. 3. Postcards lack the intimacy and implied exclusivity that comes with a per dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod onal letter in a closed-face
envelope with a real stamp. 4. Postcards are not confidential. Even the letter carrier knows what they are promoting. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Financial
planners shouldn’t use a postcard to generate a
private sales appointment any more than they should
mail a postcard to invite family me tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen bers to a
wedding. Wedding invitations are private and
personalized. Postcards are public and
generic. Postcards work at filling seminar rooms b t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel cause a
potential customer who receives the invitation knows
the event is public and that the prospect doesn’t
have to disclose any confidential ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nformation. So
attending sounds painless. The prospect will learn
something, and get a free meal. But a prospect who receives a postcard inviting y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products er
to a face-to-face meeting between her and an
unknown
financial planner is less likely to respond. She cannot
sit at the back of the room. Or . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de remain silent. She
knows she will be required to disclose some
confidential information about her financial matters.
She might attend if the invi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ation she receives is
personal and private. But she’s likely to toss it and
stay home if it arrives looking mass produced, generic
and impersonal tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Stress Management Techniques - The Top 5 To Cultivate to Succeed at Work Using a Niche as a Market Strategy
|